Pediatrics. 2011 Apr;127(4):785-7. doi: 10.1542/peds.2011-0095. Epub 2011 Mar 28.
The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends reducing the number of doses from 5 to 4 of human diploid cell vaccine or purified chick embryo cell vaccine required for postexposure prophylaxis to prevent rabies in humans. The vaccine doses should be given on day 0 (first day of prophylaxis) and days 3, 7, and 14 after the first dose. For persons with immune suppression, the 5-dose regimen should continue to be used. Recommendations for the use of human rabies immunoglobulin remain unchanged. The American Academy of Pediatrics endorses these recommendations.
美国疾病控制与预防中心免疫实践咨询委员会建议减少人二倍体细胞疫苗或鸡胚细胞纯化疫苗用于暴露后预防狂犬病所需的剂量，从 5 剂减至 4 剂。疫苗剂量应在第 0 天（预防的第一天）和第一剂后第 3、7 和 14 天给予。对于免疫抑制者，应继续使用 5 剂方案。人用狂犬病免疫球蛋白的使用建议保持不变。美国儿科学会认可这些建议。
